Abiopharma

🔍 BRYNJELSEN SEAN (Director)

Company: Eton Pharmaceuticals, Inc. (ETON)

Report Date: 2026-08-19

Detailed Transactions and Holdings:

• Sold 8,978 shares of Common Stock at $62.65 per share (Direct)
  Date: 2026-08-19 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,052,216.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 47,307 shares of Common Stock at $60.17 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,004,909.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 36,373 shares of Common Stock at $61.11 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 968,536.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 7,342 shares of Common Stock at $62.12 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 961,194.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: The shares were sold in multiple trades at prices ranging from $62.50 to $63.41. The price above reflects the weighted average sales price.
• F2: The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
• F3: The shares were sold in multiple trades at prices ranging from $59.59 to $60.59. The price above reflects the weighted average sales price.
• F4: The shares were sold in multiple trades at prices ranging from $60.61 to $61.61. The price above reflects the weighted average sales price.
• F5: The shares were sold in multiple trades at prices ranging from $61.63 to $62.52. The price above reflects the weighted average sales price.